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Abstract
Background
TREK-1 deficient alveolar epithelial cells (AECs) secrete less IL-6, more MCP-1, and con-
tain less F-actin. Whether these alterations in cytokine secretion and F-actin content are
related remains unknown. We now hypothesized that cytokine secretion from TREK-1-defi-
cient AECs was regulated by cytoskeletal rearrangements.
Methods
We determined F-actin and α-tubulin contents of control, TREK-1-deficient and TREK-1-
overexpressing human A549 cells by confocal microscopy and western blotting, and mea-
sured IL-6 and MCP-1 levels using real-time PCR and ELISA.
Results
Cytochalasin D decreased the F-actin content of control cells. Jasplakinolide increased the
F-actin content of TREK-1 deficient cells, similar to the effect of TREK-1 overexpression in
control cells. Treatment of control and TREK-1 deficient cells with TNF-α, a strong stimulus
for IL-6 and MCP-1 secretion, had no effect on F-actin structures. The combination of TNF-
α+cytochalasin D or TNF-α+jasplakinolide had no additional effect on the F-actin content or
architecture when compared to cytochalasin D or jasplakinolide alone. Although TREK-1
deficient AECs contained less F-actin at baseline, quantified biochemically, they contained
more α-tubulin. Exposure to nocodazole disrupted α-tubulin filaments in control and TREK-
1 deficient cells, but left the overall amount of α-tubulin unchanged. Although TNF-α had no
effect on the F-actin or α-tubulin contents, it increased IL-6 and MCP-1 production and se-
cretion from control and TREK-1 deficient cells. IL-6 and MCP-1 secretions from control and
TREK-1 deficient cells after TNF-α+jasplakinolide or TNF-α+nocodazole treatment was
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similar to the effect of TNF-α alone. Interestingly, cytochalasin D decreased TNF-α-induced
IL-6 but not MCP-1 secretion from control but not TREK-1 deficient cells.
Conclusion
Although cytochalasin D, jasplakinolide and nocodazole altered the F-actin and α-tubulin
structures of control and TREK-1 deficient AEC, the changes in cytokine secretion from
TREK-1 deficient cells cannot be explained by cytoskeletal rearrangements in these cells.
Introduction
We previously identified the 2-pore domain potassium (K2P) channel TREK-1 as an important
molecule in the regulation of alveolar epithelial cell (AEC) cytokine secretion[1–3], cell detach-
ment[4] and proliferation[1]. Our data revealed that TREK-1 deficient AECs secrete lower
amounts of IL-6 but increased amounts of MCP-1 upon TNF-α stimulation[1–3]. Further-
more, in an in vivomodel of Acute Lung Injury (ALI) we recently found that TREK-1 deficien-
cy led to increased lung damage and AEC apoptosis but decreased BAL cytokine levels[5]. In a
separate study, we recently reported that TREK-1 deficient AECs contained lower amounts of
F-actin and these cells appeared more resistant to stretch-induced injury[4].
Based on these results, the main goal of this study was to determine whether the alterations in
cytokine secretion from TREK-1 deficient AECs were caused by changes in the cytoskeletal fila-
ment content and organization observed in these cells. We hypothesized that the impaired IL-6
secretion from TREK-1 deficient AECs was related to the decreased F-actin content of these
cells, whereas the increased secretion of MCP-1 was unrelated to cytoskeletal derangements.
In general, inflammatory mediators such as cytokines and other soluble molecules are
thought to be packaged in the Golgi apparatus into secretory vesicles, or so-called Secretory
Carrier Membrane Proteins (SCAMPs)[6], and transported to the correct location at the plas-
ma membrane along a cytoskeletal network of F-actin fibers and microtubules[7–12]. This
phenomenon is best described in inflammatory cells and is commonly known as compound
exocytosis[13,14]. Unfortunately, little is known about the molecular mechanisms regulating
mediator secretion from AECs and their contribution to lung inflammation and lung injury.
Nevertheless, the cytoskeleton appears to play an active role in AECs in the secretion of
both soluble inflammatory mediators such as cytokines and chemokines[15,16] as well as reac-
tive oxygen[17] and nitrogen species[18]. Specifically, in AECs a role for F-actin and microtu-
bules has been proposed for the secretion of TNF-α, IL-6, MCP-1, IL-8[16,19–21], surfactant
[22] and fibrinogen[23]. However, most of these studies were conducted in infectious models
of lung inflammation, and the authors often attributed the F-actin-mediated changes in cyto-
kine secretion to a decreased ability of AECs to engulf bacteria, which subsequently resulted in
decreased cytokine production[21,24,25]. To the best of our knowledge, the relationship be-
tween potassium channel expression, regulation of cytoskeletal structures, and inflammatory
mediator secretion from AECs has never been studied. Here we report that in AECs TREK-1
regulates the content and architecture of cytoskeletal filaments, but these changes do not affect
the production or secretion of IL-6 or MCP-1.
Materials and Methods
Cell culture
Human A549 AECs were purchased from the American Type Culture Collection (ATCC, Ma-
nassas, VA). Cells were cultured in DMEM (Gibco, Carlsbad, CA) supplemented with 10%
Cytoskeletal Derangements in TREK-1 Deficient Cells
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FBS (Gibco), 1% Penicillin/Streptomycin (Gibco), 20mMHEPES (Sigma Aldrich, St. Louis,
MO), and 2mM L-Glutamine (Gibco). A stable TREK-1 deficient A549 cell line and a control
cell line transfected with a scrambled shRNA were created as previously described[3].
A stable TREK-1 over-expressing A549 cell line was created as described previously[2]
using an Origene TrueORF Gold cDNA Clones and Precision Shuttle Vector system
(cat#RC210180) by following to the manufacturer’s instructions. Details of the pCMV6-Entry
vector containing a DDK-tag for detection are available on the Origene website (www.origene.
com/cdna/trueorf/destinationvector.mspx). Briefly, 3x105 cells were grown in 6 well plates
prior to transfection until cells reached 60–70% confluence in DMEMmedium supplemented
with 10% FBS, 20mMHEPES and 2mM L-Glutamine. Cells were transfected with the DNA
probe provided by the manufacturer using the Turbofectin 8.0 transfection system and incu-
bated for 24 hours at 37°C. To select for positively transfected cells, cells were cultured in T75
flasks in DMEMmedium (10% FBS, 1% Penicillin/Streptomycin, 20mMHEPES and 2mM
L-Glutamine) supplemented with 0.5 mg/mL G418. As a control, non-transfected A549 cells
were cultured in parallel under the same conditions. TREK-1 over-expression was confirmed
by Western Blot and real time PCR[2].
Trek-1 deficient and control cells were incubated in the presence or absence of TNF-α
(5 ng/ml), jasplakinolide (0.05 μM, Sigma), cytochalasin D (0.1 μM, Sigma), or nocodazole
(0.1μM, Sigma). Cell toxicity was monitored by trypan blue staining and determination of total
intracellular protein concentrations using the Bradford assay. We found>90% cell viability
under all conditions, as in our previous studies[2,3].
Confocal Microscopy
Cells were grown to 80–90% confluence and then fixed with 4% paraformaldehyde for 5 min at
4°C, permeabilized with 0.5% Triton X-100 for 10 min, and then blocked with 2% BSA in PBS
for 30 min. The cells were then incubated with Rhodamine Phalloidin (1:150, Cytoskeleton,
CO) for F-actin staining or an anti-α-tubulin Alexa 488 antibody (1:200, Invitrogen) for
30 min at room temperature. Nuclear staining was obtained using Fluoro Gel II mounting me-
dium containing DAPI (Electron Microscopy Sciences, Hatfield, PA). Images were acquired
using a Zeiss 710 confocal imaging system. Emitted fluorescence was collected using a 60x
magnification objective lens (NA 1.4 Oil), and the images were recorded using Zen 2009 Light
Edition software (Zeiss).
G- and F-actin assay by Western blot
G- and F-actin fractions were collected as previously described[4]. Briefly, cells were seeded in
6 well culture plates (0.3x106 cells/well) in triplicate and grown to>90% confluence. Cells were
washed twice with cold PBS and then lysed in the following solution for 5 min on ice: 1% Tri-
ton X-100, 20 mM Tris, 5 mM EGTA, 20 mMNaFl, 25 mM Na pyrophosphate, containing a
protease inhibitor cocktail (Roche, Burlington, NC). G-actin containing supernatants were
collected and total protein concentrations were determined using the Quick Start Bradford
(BioRad, Hercules, CA). Thereafter, F-actin was extracted by adding the following solution: 1%
Triton X-100, 20 mM Tris, 5 mM EGTA, 20 mMNaFl, 25 mM Na pyrophosphate, containing
a protease inhibitor cocktail (Roche, Burlington, NC) and 5% SDS and 5% deoxycholic acid.
After 5 min, samples containing F-actin were removed from the wells using a cell scraper and
the samples were centrifuged at 17,000 x g for 20 min at 4°C. To determine the relative
amounts of G- and F-actin, we performed western blot experiments loading equal sample vol-
umes per lane and blotted with an antibody against actin (1:1000, Cytoskeleton, CO). GAPDH
(1:2000, Cell Signaling) was used as an internal loading control for G-actin. Since F-actin
Cytoskeletal Derangements in TREK-1 Deficient Cells
PLOS ONE | DOI:10.1371/journal.pone.0126781 May 22, 2015 3 / 20
filaments remain attached to the substrate after removal of the G-actin fraction with all other
cytosolic components, F-actin can only be normalized to G-actin, but not to cytosolic proteins
such as GAPDH or β–actin. Therefore, G-actin concentrations were normalized to GAPDH
and data were then expressed as F-actin to total actin (G+F-actin) ratios. Band densities for α-
tubulin were normalized to GAPDH. All band densitometry analyses to determine relative
quantities of proteins were performed using ImageJ 1.42 software for Windows.
Gene expression by Real-Time PCR
Total RNA was isolated from 2x106 control or TREK-1 deficient A549 cells using a High Pure
RNA Isolation Kit (Roche Applied Science, Mannheim, Germany) according to the manufac-
turer’s instructions. Single-stranded DNA was synthesized from 1 μg total RNA and Reverse
Transcription PCR was performed using a High Capacity cDNA Reverse Transcription kit
(Applied Biosystems, CA) according to the manufacturer’s instructions. Real-Time PCR was
performed using a TaqMan Gene Expression assay (Roche). Primer sets for human IL-6 were
purchased from Cell Signaling and primer sets for MCP-1 were purchased from IDT as previ-
ously described[2,3]. In preliminary experiments we confirmed that HGPRT levels were un-
changed between control and TREK-1 deficient A549 cells and, therefore, IL-6 and MCP-1
mRNA levels were normalized to HGPRT expression. All experiments were repeated 4 times
and each sample was run in triplicates.
IL-6 and MCP-1 ELISA measurements
IL-6 and MCP-1 secretion in A549 cell supernatants was measured as previously described
[2,3]. Briefly, 1x105 control, TREK-1 deficient or overexpressing cells were seeded in 12-well
culture plates and grown to 80–90% confluence. Cells were then incubated in complete culture
medium in the presence or absence of TNF-α, jasplakinolide (0.05 μM), cytochalasin D
(0.1 μM), or nocodazole (0.1 μM) for 2 or 6 hours at 37°C. Total intracellular protein concen-
trations were measured in each experiment using the Bradford assay and remained consistent
under all experimental conditions, suggesting that there was no non-specific leakage of intra-
cellular proteins. Cytokine concentrations were determined from sample supernatants using
species-specific IL-6 and MCP-1 ELISA kits (BD Bioscience OptEIA following the manufactur-
er’s instructions.
Statistical analysis
All values were expressed as mean ± SEM and statistical analysis was performed using Stu-
dent’s t-test or ANOVA. All statistical analyses were performed using SigmaStat 3.5 software
and a p-value of p<0.05 was considered significant.
Results
Regulation of F-actin and α-tubulin filaments in control, TREK-1 deficient
and TREK-1 overexpressing AECs
To test the hypothesis that TREK-1-mediated changes in cytoskeletal structures regulate
cytokine secretion from AECs, we manipulated the architecture of F-actin filaments with cyto-
chalasin D (a potent inhibitor of actin polymerization[26,27]), jasplakinolide (a drug known to
promote and stabilize actin polymerization[28,29]), TNF-α (a strong stimulus for cytokine se-
cretion from AECs[2,3]), and by overexpressing TREK-1 protein in AECs (Fig 1).
Treatment of AECs with cytochalasin D for 6 hours disrupted F-actin filaments in control
(Fig 1B) and TREK-1 deficient cells (Fig 1G), whereas jasplakinolide increased the F-actin
Cytoskeletal Derangements in TREK-1 Deficient Cells
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content in both cell types (Fig 1C and 1H). Similarly, TREK-1 overexpression also increased
the F-actin content in control cells (Fig 1K). TREK-1 deficient cells contained lower amounts
of F-actin at baseline[4] (Fig 1F). Treatment of control and TREK-1 deficient cells with TNF-α
had no effect on F-actin filaments when compared to untreated cells (Fig 1D and 1I), and the
combination of TNF-α+cytochalasin D or TNF-α+jasplakinolide had no additional effect on
F-actin filaments when compared with cytochalasin D or jasplakinolide alone, respectively. To
observe time-dependent changes in cytoskeletal remodeling, we also exposed AECs to these
drugs for 2 hours instead of 6 hours and found similar results (data not shown).
Densitometry quantification of F-actin to total (G+F-actin) actin ratios revealed a decrease
in the F/total actin content in control cells after 2 and 6 hours of cytochalasin D treatment by
45% and 66%, respectively (Fig 2A and 2B). Exposure of control cells to TNF-α+cytochalasin
D for 2 or 6 hours had no further effect on the F/total actin content when compared to cytocha-
lasin D treatment alone. Exposure of TREK-1 deficient cells to 2 or 6 hours of jasplakinolide in-
creased the F/total actin content by 57% and 85%, respectively, but the combination of TNF-α
+jasplakinolide had no further effect on the F/total actin content when compared to jasplakino-
lide alone (Fig 2C and 2D).
Furthermore, exposure of control cells to jasplakinolide increased the F/total actin content
by 64% (Fig 3A and 3B), whereas cytochalasin D had no further effect on the F/total actin con-
tent in TREK-1 deficient cells (Fig 3C and 3D). Similar to jasplakinolide-treated cells, TREK-1
overexpression increased the F/total actin content (73% increase over control; Fig 3E and 3F).
Interestingly, at baseline, TREK-1 deficient cells contained increased amounts of α-tubulin
when compared to control cells as shown by confocal microscopy (Fig 4) andWestern blot ex-
periments (Fig 5). Nocodazole disrupted α-tubulin filaments and resulted in perinuclear accu-
mulation of α-tubulin filaments in both control and TREK-1 deficient cells (Fig 4). Treatment
of control and TREK-1 deficient cells with TNF-α had no effect on α-tubulin filaments when
compared to untreated cells, and the combination of TNF-α+nocodazole had no additional ef-
fect on α-tubulin filaments when compared with nocodazole alone. These findings were con-
firmed by densitometry analysis of 5 separate experiments (Fig 5).
In contrast to TREK-1 deficient cells, TREK-1 overexpressing cells contained lower
amounts of α-tubulin as shown by confocal microscopy (Fig 4) and by Western blot (Fig 5).
GAPDH immunoblots confirmed equal loading conditions.
The alterations in IL-6 and MCP-1 secretion from TREK-1 deficient cells
were not caused by cytoskeletal derangements
Exposure of control cells to TNF-α for 2 and 6 hours resulted in a 4.3-fold and 7.8-fold increase
in IL-6 secretion, respectively, when compared to untreated cells, while TREK-1 deficient cells
released much lower amounts of IL-6 both at baseline and after TNF-α stimulation (Fig 6A
and 6B)[3]. Neither jasplakinolide nor nocodazole altered baseline or TNF-α-induced IL-6 se-
cretion from control or TREK-1 deficient cells, respectively (Fig 6A and 6B). However, cyto-
chalasin D decreased IL-6 secretion from control but not TREK-1 deficient cells at both time
points (Fig 6A and 6B). In the presence of TNF-α, the inhibitory effect of cytochalasin D on IL-
6 release from control cells was no longer observed at either time point.
Fig 1. Regulation of F-actin architecture in control, TREK-1 deficient and TREK-1 overexpressing
cells.Confocal images using rhodamine-phalloidin staining (red) for F-actin filaments in untreated cells and
after 6 hours of treatment with cytochalasin D (0.1 μM), jasplakinolide (0.05 μM) and TNF-α (5 ng/mL), or the
combination of TNF-α+cytochalasin D or TNF-α+jasplakinolide. Inserts 1, 2 and 3 show the F-actin structures
of a single control, TREK-1 shRNA or TREK-1 overexpressing cell, respectively. Nuclei are stained with DAPI
(blue); images are representative of 4 separate experiments.
doi:10.1371/journal.pone.0126781.g001
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Exposure of TREK-1 overexpressing cells to TNF-α for 2 or 6 hours caused no further in-
crease in IL-6 secretion when compared to untreated controls (Fig 6C).
As noted previously[2], at baseline and after TNF-α stimulation, TREK-1 deficient cells se-
creted increased amounts of MCP-1 when compared to control cells (Fig 7A and Fig 7B). After
2 and 6 hours of TNF-α stimulation, MCP-1 secretion was increased by 6.7-fold and 15-fold,
respectively, when compared to untreated TREK-1 deficient cells (Fig 7A and Fig 7B). Cytocha-
lasin D, jasplakinolide and nocodazole had no effect on baseline or TNF-α-induced MCP-1 se-
cretion from control or TREK-1 deficient cells.
Therefore, it is unlikely that the alterations in IL-6 and MCP-1 secretion from TREK-1 defi-
cient cells were caused by the cytoskeletal derangements observed in these cells.
Cytoskeletal derangements did not cause alterations in IL-6 and MCP-1
gene expression in TREK-1 deficient cells
To determine whether in TREK-1 deficient AECs cytoskeletal derangements caused alterations
in cytokine secretion by affecting IL-6 and MCP-1 gene expression, we investigated the effects
of cytochalasin D, jasplakinolide and nocodazole on IL-6 and MCP-1 mRNA levels using real-
time PCR (Fig 8A and 8B). At baseline, untreated TREK-1 deficient cells expressed lower
amounts of IL-6 mRNA but higher amounts of MCP-1 mRNA than control cells. Treatment
with cytochalasin D, jasplakinolide or nocodazole did not affect baseline IL-6 or MCP-1 gene
expression in control or TREK-1 deficient cells. Similarly, treatment of control and TREK-1 de-
ficient cells with TNF-α or the combination of TNF-α+cytochalasin D, TNF-α+jasplakinolide
or TNF-α+nocodazole had no additional effect on IL-6 and MCP-1 gene expression over TNF-
α alone. Although TREK-1 deficient cells contained lower amounts of IL-6 mRNA, the overall
fold increase in IL-6 gene expression induced by TNF-α was similar between control and
TREK-1 deficient cells when compared to their respective untreated controls. In contrast,
MCP-1 mRNA levels increased more in TREK-1 deficient cells that in control cells after TNF-
α stimulation.
Discussion
In this study we showed for the first time that epithelial production and secretion of IL-6 and
MCP-1, two important cytokines in the development of Acute Lung Injury (ALI) and Acute
Respiratory Distress Syndrome (ARDS)[30,31], can occur independently of F-actin and α-tu-
bulin cytoskeletal rearrangements. Importantly, not only do TREK-1 deficient AECs contain
decreased amounts of F-actin[4], but we now report that they also contain increased amounts
of α-tubulin. The main goal of this study was to determine whether the distinct cytokine secre-
tion patterns from TREK-1 deficient AECs were caused by changes in the cytoskeletal filament
content and structure of these cells.
We are still in the early stages of understanding the role for TREK-1 in the regulation
of AEC activation and its contribution to the development of ALI/ARDS[1–3,5]. In
previous studies we found that NFkB, p38 kinase and JNK kinase are unlikely involved in
Fig 2. Quantification of normalized F-actin contents in control and TREK-1 deficient cells.
Representative western blot experiments and densitometry analysis of cytochalasin D-treated control (Fig 2A
and Fig 2B) and jasplakinolide-treated TREK-1 deficient cells (Fig 2C and Fig 2D) in the presence or absence
of TNF-α. Importantly, only soluble G-actin can be normalized to GAPDH since F-actin was collected after all
soluble components (including intracellular GAPDH) were removed in the G-actin sample. However, G-actin,
F-actin and GAPDH samples for the respective time points were run and analyzed from the same gel; the
blots are separated in the figure to conserve space and to facilitate comparison. *compared to untreated
control or #TREK-1 deficient cells at the 2 and 6 hour time points, respectively. n = 5.
doi:10.1371/journal.pone.0126781.g002
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TREK-1-mediated cytokine secretion, whereas PKCθ appeared to regulate IL-6 but not MCP-1
secretion[2,3]. However, the role of the cytoskeleton in epithelial mediator secretion remains
poorly understood and is of particular interest in light of the astonishing cytoskeletal changes
observed in TREK-1 deficient cells at baseline. Importantly, a role for the cytoskeleton in
Fig 3. Normalized F-actin contents in control, TREK-1 deficient and TREK-1 overexpressing cells.Representative Western blot experiments and
densitometry analysis showing the effects of jasplakinolide on control cells (Fig 3A and Fig 3B) and of cytochalasin D on TREK-1 deficient cells (Fig 3C and
Fig 3D). Fig 3E shows an increase in the normalized F-actin content in TREK-1 overexpressing cells. Each lane represents a separate experiment. GAPDH
was used as a loading control. *compared to untreated control cells. n = 5.
doi:10.1371/journal.pone.0126781.g003
Cytoskeletal Derangements in TREK-1 Deficient Cells
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cytokine secretion from secretory cells has been described in several studies. Various modes of
exocytosis and mediator release, including compound exocytosis, “kiss-and-run” exocytosis,
and “full-collapse-fusion” exocytosis, have been described in different secretory cells
Fig 4. Confocal images of α-tubulin contents and architecture.Confocal images of α-tubulin staining
(green) in control, TREK-1 deficient and TREK-1 overexpressing cells in the presence or absence of
nocodazole, TNF-α, or the combination of TNF-α+nocodazole for 6 hours. Representative images of 4
separate experiments.
doi:10.1371/journal.pone.0126781.g004
Cytoskeletal Derangements in TREK-1 Deficient Cells
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[13,14,32,33]. All these mechanisms imply a role for cytoskeletal structures in the transport of
mediator-containing vesicles from the Golgi apparatus to the plasma membrane[34–36]. For
instance, activation of pancreatic β-cells resulted in F-actin reorganization promoting the
transport of insulin-containing granules to the plasma membrane[36], and in eosinophils toxic
granules translocated to the plasma membrane during apoptosis via F-actin rearrangements
[17]. Interestingly, Bengtsson et al. showed in neutrophils that disruption of F-actin filaments
with cytochalasin D resulted in increased neutrophil degranulation whereas accumulation of
F-actin filaments with tertracaine inhibited mediator secretion[37]. The authors explained
these findings by accumulation of F-actin filaments in the cell periphery thereby obstructing
secretory granules from fusing with the plasma membrane. Our data showed that neither dis-
ruption nor stabilization of F-actin fibers altered TNF-α-induced production or secretion of
IL-6 and MCP-1 from control and TREK-1 deficient AECs, respectively. Therefore, the intrin-
sic scarcity of F-actin fibers present in TREK-1 deficient cells is unlikely the cause for the de-
creased amounts of IL-6 secreted from these cells.
A role not only for F-actin but also for microtubules in mediator secretion has been de-
scribed in NK cells, where F-actin stabilization with jasplakinolide trapped lytic granules within
an F-actin mesh[38]. Other groups proposed that in activated NK cells specific areas within
Fig 5. Quantification of the α-tubulin content. Representative Western Blot experiment and densitometric analysis of untreated, nocodazole-treated and
TNF-α-treated control and TREK-1 deficient cells. *compared to untreated control cells at the 2 hour time point, #compared to untreated control cells at the 6
hour time point. n = 5.
doi:10.1371/journal.pone.0126781.g005
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Fig 6. IL-6 secretion was not affected by alterations in F-actin or α-tubulin structures. IL-6 secretion from control and TREK-1 deficient cells was
measured after exposure to cytochalasin D (Cyto D), jasplakinolide (Jasp), nocodazole (noco) with or without TNF-α for 2 (Fig 6A) or 6 hours (Fig 6B). TREK-
1 overexpression had no additional effect on TNF-α-induced IL-6 secretion Fig 6C). *compared to untreated control cells; ^compared to untreated TREK-1
deficient cells; #TNF-α-stimulated control cells with and without cytochalasin D. n = 6–9.
doi:10.1371/journal.pone.0126781.g006
Fig 7. MCP-1 secretion was not affected by alterations in F-actin or α-tubulin structures.MCP-1
secretion from control and TREK-1 deficient cells was measured after exposure to cytochalasin D (Cyto D),
jasplakinolide (Jasp), nocodazole (noco) with or without TNF-α for 2 (Fig 7A) or 6 hours (Fig 7B). *compared
to untreated control cells; #compared to untreated TREK-1 deficient cells. n = 6–9.
doi:10.1371/journal.pone.0126781.g007
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this F-actin mesh opened and created gaps large enough for granules to penetrate and get se-
creted[39,40]. Similar mechanisms appear to exist in CD4+ T cells where F-actin and microtu-
bule rearrangements cleared the path for secretory granules to reach the plasma membrane
[41]. In contrast, in monocytes, secretion of matrix metalloproteinase-9 was inhibited after dis-
ruption of F-actin filaments and microtubules with cytochalasin B and nocodazole[42]. Similar
to monocytes, mediator secretion from antigen-stimulated mast cells[43] and from neuronal
cells[44] was impaired after disruption of microtubules with colchicine. In our hands, disrup-
tion of microtubules with nocodazole had no effect on baseline or TNF-α-induced IL-6 or
MCP-1 production or secretion from control and TREK-1 deficient AECs.
Interestingly, TREK-1 deficient cells contained increased amounts of α-tubulin at baseline
but the significance and the underlying mechanisms for this finding remain to be determined.
Currently we can only speculate on how TREK-1 deficiency results in increased α-tubulin lev-
els. We know that in neuronal cells a crosstalk exists between TREK-1 and the F-actin network
Fig 8. IL-6 andMCP-1 gene expression was not affected by alterations in F-actin or α-tubulin
structures. IL-6 (Fig 8A) and MCP-1 (Fig 8B) mRNA expression was determined by quantitative real-time
PCR in control and TREK-1 deficient cells exposed to 6 hours of cytochalasin D (Cyto D), jasplakinolide
(Jasp) or nocodazole (Noco) in the presence or absence of TNF-α. Data were normalized to HGPRT
expression and are expressed as fold-change in gene expression from untreated control cells. *compared to
untreated control cells. #compared to untreated TREK-1 deficient cells. A 2-fold change in gene expression
was considered significant. n = 4.
doi:10.1371/journal.pone.0126781.g008
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[45], but whether similar direct interactions exists between TREK-1 and α-tubulin is unknown.
We have previously reported that TREK-1 deficiency affected IL-6 mRNA expression[3], and
it is possible that TREK-1 similarly affects α-tubulin gene expression. Alternatively, TREK-1
could be a regulatory protein in α-tubulin synthesis. In neurons for example, TREK-1 protein
expression can induce the formation of actin- and ezrin-rich membrane protrusions[45], and
deficiency of TREK-1 resulted in a decrease in the F-actin content of these cells[46]. Altogether,
our data suggest that neither the architecture nor the content of F-actin and α-tubulin fila-
ments play a major role in IL-6 and MCP-1 production and secretion from AECs.
Of particular interest is the fact that although TREK-1 deficient cells contained lower
amounts of IL-6 mRNA, the overall fold increase in IL-6 gene expression induced by TNF-α
was similar between control and TREK-1 deficient cells when compared to their respective un-
treated controls. In contrast, MCP-1 mRNA levels increased more in TREK-1 deficient cells
that in control cells after TNF-α stimulation. These data give important insight into the regula-
tory mechanisms underlying IL-6 and MCP-1 production and secretion in TREK-1 deficient
AECs. Together with our previously published data showing that the majority of IL-6 and
MCP-1 in AECs is newly synthesized[2,3], the results of this study suggest that IL-6 secretion
is predominantly regulated post-transcriptionally, whereas MCP-1 secretion is regulated at the
transcriptional level. Interestingly, while TREK-1 deficiency resulted in decreased IL-6 and in-
creased MCP-1 secretion from both mouse[1] and human alveolar epithelial cells[2,3], overex-
pression of TREK-1 had no further effect on MCP-1 secretion when compared to control cells
[2].
Particular attention needs to be exerted when interpreting the effects of cytoskeleton alter-
ing-agents on mediator release from immune and inflammatory cells. While manipulation of
F-actin filaments and microtubules can ultimately result in alterations in inflammatory media-
tor secretion, many of the studies point out that the underlying mechanisms may be linked to
impaired phagocytosis of bacteria and impaired immune cell activation caused by the disrup-
tion of cytoskeletal structures rather than by impaired transport of secretory vesicles to the
plasma membrane[11,19]. Interestingly, similar findings were observed in lung epithelial A549
cells where inhibition of MCP-1 and IL-8 release was linked to impaired internalization of E.
coli bacteria after treatment with cytochalasin D rather than impaired vesicle secretion[20].
Similarly, deceased IL-8 secretion from smoke-exposed A549 cells after cytochalasin D treat-
ment was linked to impaired smoke particle uptake rather than secretory vesicle transport[15].
A further complicating step in understanding these mechanisms is added by the fact that recy-
cling of cytokine and chemokine plasma membrane receptors is generally regulated by cyto-
skeletal rearrangements[14,47,48]. Therefore, secretion of inflammatory mediators after
disruption of cytoskeletal structures could be due to impaired receptor activation and signaling,
in addition to defective vesicle secretion.
Unfortunately, our understanding of the secretory mechanisms of lung epithelial cells lags
far behind immune and inflammatory cells. Advancing this field is absolutely critical, particu-
larly as epithelial cells emerge as a major contributor to the inflammation observed in ALI/
ARDS[49–51]. It appears that the effects of cytoskeletal rearrangements on inflammatory me-
diator secretion are, at least in part, cell type-specific and can both promote or inhibit cytokine
release depending on the activation process, as noted above. We also need further studies tar-
geting the molecular signaling mechanisms that regulate cytoskeletal rearrangements upon epi-
thelial cell activation, including the role of stretch-activated ion channels, such as TREK-1, in
epithelial mechano-transduction. Although the gating mechanisms of several ion channels are
regulated by cytoskeletal rearrangements[52,53], little is known about the effects of specific ion
currents on F-actin and microtubule polymerization and depolymerization. Similarly, in the
anterior eye chamber TREK-1 expression caused cytoskeletal changes in response to stretch
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[54]. Although TREK-1 expression can alter the cytoskeletal structure of various cell types
including AECs, we found no effect of such cytoskeletal rearrangements on AEC mediator
secretion.
In our hands, we did not observe significant changes in F-actin content or architecture after
treatment of control and TREK-1 deficient A549 cells with TNF-α. Nevertheless, exposure of
other cell types to TNF-α has been reported to cause significant F-actin rearrangements. For
example, cultured pulmonary endothelial cells responded to TNF-α treatment with F-actin
thickening and bundling along the cell periphery[55]. It needs to pointed out, however, that
the TNF-α dose used in that particular study was four times higher (20 ng/mL) than the dose
used in our study (5 ng/mL). In dermal endothelial cells, TNF-α exposure induced an increase
in F-actin stress fibers as early as 1–3 hours after treatment, but the dose used was again higher
than in our study[56]. A similar F-actin reorganization was observed in immortalized corneal
epithelial cells[57] but cells were once again exposed to a higher TNF-α dose (10 ng/mL) and
were treated longer (for 24 hours).
To the best of our knowledge, the only study addressing TNF-α-induced F-actin reorganiza-
tion in lung A549 epithelial cells used 100 ng/ml TNF-α (20-fold higher than our dose) for 48
hours (4 times longer)[58]. In our preliminary studies, such a protocol resulted in significant
cell toxicity (data not shown). In another immortalized human adenocarcinoma cell line,
H441-4, exposure to TNF-α concentrations up to 100 ng/mL for 48 hours showed no effect on
the total actin content, but effects on the F-actin architecture were not reported in that study
[59]. We chose a TNF-α dose of 5 ng/mL and an exposure time of up to 6 hours because these
conditions induced substantial changes in cytokine gene expression and protein secretion with-
out significant cell toxicity. It is possible that at higher TNF-α doses or after longer exposure
periods we would find changes in the F-actin content or architecture in our cells. Furthermore,
freshly isolated murine or rat AT II cells may respond to the same treatment conditions differ-
ently than cultured human A549 cells. It is, therefore, important to acknowledge that, while
TNF-α did not induce cytoskeletal rearrangements in our system, it is well known that it can
cause cytoskeletal changes in other cell types[55,57]. However, most of these effects are re-
ported at higher concentrations or longer time periods than the one used in our study.
Limitations of this study include the fact that the experiments were performed in human
immortalized cells (A549) rather than in primary cells. However, human A459 cells are a wide-
ly accepted model for alveolar epithelial cell biology[60,61]. Furthermore, compared to other
alveolar cell lines such as murine MLE-12 cells, human A549 cells secrete higher amounts of in-
flammatory cytokines and represent a more homogeneous cell population than MLE-12 cells
[1,3]. One of the concerns in using a transformed cell line consists in potential non-specific ef-
fects caused by the shRNA probe. In preliminary experiments we had confirmed that no non-
specific or compensatory changes in the expression of TREK-1-related channels, such as
TREK-2 or TRAAK, or in other stretch-activated ion channels such as the Ca2+-permeable
TRPV4 had occurred (data not shown).
In conclusion, in this study we show for the first time that in TREK-1 deficient AECs alter-
ations in cytokine production and secretion and cytoskeletal derangements occur simulta-
neously but do not appear to be related. In fact, neither polymerization nor depolymerization
of cytoskeletal structures in TREK-1 deficient AECs affected TNF-α-induced IL-6 and MCP-1
gene expression or protein secretion. While the molecular mechanisms underlying these find-
ings require further investigation, TREK-1 remains an important target in the search for new
approaches against AEC activation in the context of ALI/ARDS.
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